Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease
NCT06876363
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
X-Linked Chronic Granulomatous Disease
Interventions
GENETIC:
EN-374
Sponsor
Ensoma